Conversant Bio Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Merger of Eq.
  • Financing Rounds
  • 1
  • Investments
  • 2

Conversant Bio General Information

Description

Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procurement of human primary cells from peripheral blood, bone marrow, processed and whole tissue as well as assessment of tumor tissues for scientific investigations, enable clients to develop new medicines and diagnostic tools.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Primary Office
  • 601 Genome Way
  • Suite 1200
  • Huntsville, AL 35806
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Conversant Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conversant Bio‘s full profile, request access.

Request a free trial

Conversant Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procu
Laboratory Services (Healthcare)
Huntsville, AL
00000000000

00000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
Vancouver, Canada
0000 As of 0000
000.00
00000000. 00 000.00

000000 0

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
00000 000000000000000 000 0000000000000
Glasgow, United Kingdom
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Conversant Bio Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
StemCell Technologies Private Equity-Backed Vancouver, Canada 0000 000.00 00000000. 00 000.00
000000 000000000 0 Corporation Glasgow, United Kingdom
0000 000000000000 Corporation San Diego, CA 0 000000000 -
00000000 000000000 Private Equity-Backed Lexington, MA 00 000.00 000000000000
000000 0000000000 Private Equity-Backed Nottingham, United Kingdom 000 000.00 00000000 000.00
To view Conversant Bio’s complete competitors history, request access »

Conversant Bio Executive Team (4)

Name Title Board Seat Contact Info
Will Taylor Chief Financial Officer
Jay Scherer Chief Operating Officer
Luke Doiron Co-Founder, Chief Commercial Officer & Board Member
To view Conversant Bio’s complete executive team members history, request access »

Conversant Bio Board Members (1)

Name Representing Role Since
0000 000000 Conversant Bio Co-Founder, Chief Commercial Officer & Board Member 000 0000
To view Conversant Bio’s complete board members history, request access »

Conversant Bio Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 24-Mar-2015 00000 0000 Clinics/Outpatient Services 00000000 000000000 00.
Entopsis 18-Mar-2015 Seed Round 00000 Diagnostic Equipment
To view Conversant Bio’s complete investments history, request access »